Your browser doesn't support javascript.
loading
Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trial.
van Hellemond, Irene E G; Smorenburg, Carolien H; Peer, Petronella G M; Swinkels, Astrid C P; Seynaeve, Caroline M; van der Sangen, Maurice J C; Kroep, Judith R; de Graaf, Hiltje; Honkoop, Aafke H; Erdkamp, Frans L G; van den Berkmortel, Franchette W P J; de Roos, Wilfred K; Linn, Sabine C; Imholz, Alexander L T; de Boer, Maaike; Tjan-Heijnen, Vivianne C G.
Afiliação
  • van Hellemond IEG; Department of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Smorenburg CH; Department of Internal Medicine, Medical Centre Alkmaar, Alkmaar, The Netherlands.
  • Peer PGM; Biostatistics, Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Swinkels ACP; Clinical Research Department, Netherlands Comprehensive Cancer Organization IKNL, Utrecht, The Netherlands.
  • Seynaeve CM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • van der Sangen MJC; Department of Radiation Oncology, Catharina Hospital, Eindhoven, The Netherlands.
  • Kroep JR; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands.
  • de Graaf H; Department of Medical Oncology, Medical Centre Leeuwarden, Leeuwarden, The Netherlands.
  • Honkoop AH; Department of Medical Oncology, Isala Clinics, Zwolle, The Netherlands.
  • Erdkamp FLG; Department of Medical Oncology, Zuyderland Medical Centre, Sittard, The Netherlands.
  • van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Centre, Heerlen, The Netherlands.
  • de Roos WK; Department of Surgery, Gelderse Vallei Hospital, Ede, The Netherlands.
  • Linn SC; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Imholz ALT; Department of Medical Oncology, Deventer Hospital, Deventer, The Netherlands.
  • de Boer M; Department of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Tjan-Heijnen VCG; Department of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands. vcg.tjan.heijnen@mumc.nl.
Breast Cancer Res Treat ; 180(3): 675-685, 2020 Apr.
Article em En | MEDLINE | ID: mdl-32124136
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osteoporose / Doenças Ósseas Metabólicas / Neoplasias da Mama / Densidade Óssea / Difosfonatos / Conservadores da Densidade Óssea / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osteoporose / Doenças Ósseas Metabólicas / Neoplasias da Mama / Densidade Óssea / Difosfonatos / Conservadores da Densidade Óssea / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda